Within this study, important biomarkers concerning patients with PDAC + DM compared to PDAC were identified with the differentially expressed proteins CD166, S100A13, c-Jun, YAP, p53, and TGM2 as well as the miRNA-1285-3p. This evidence concerns the gene S100A13 and diabetes mellitus.